Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Share Post:

Strengthen Your Customer Connections

Understanding the world prescribers are living in allows for more meaningful customer interactions. MAP Training Programs build your knowledge on marketplace trends impacting providers and the pharmaceutical industry today. 

Begin learning today

Achieve Company Goals

Bring teams up-to-speed on the latest market access trends impacting their unique selling environment.

View custom training solutions

Keep Your Finger on The Pulse

Subscribe to the Marketplace Blog to stay up-to-date on the latest trends impacting pharma

*required





    Privacy Guaranteed — We will never share your info

    Marketplace Blog

    Trends in the Marketplace

    The Increasing Exploitation…

    Copay accumulator programs have only one purpose; increase profits for payers. Patients don’t gain an advantage, nor do manufacturers. On top of that, providers face

    Fractures in The 340B Program

    The 340B Program remains controversial. Hospitals and other Covered Entities (providers qualified to buy drugs at 340B prices) that benefit from the program describe it

    The Impact of Medicare Pric…

    The Inflation Reduction Act (IRA) passed on August 16th, 2022 brings big changes for the pharmaceutical industry. On August 31st we had a live discussion

    Purchasing the Program does not automatically enroll you in a live discussion session. After creating your ProFusion MAP account, you can select a live discussion session to attend. Attendance for each session is capped at 10 participants.

    All Available Sessions

    There are no upcoming events at this time

    Manufacturers Restricting 340B Sales to Contract Pharmacies

    • Abbvie
    • Amgen
    • AstraZeneca
    • Boehringer Ingelheim
    • Eli Lilly
    • Merck
    • Novartis
    • Novo Nordisk
    • Sanofi
    • UCB
    • United Therapeutics
    • and more…